发明名称 Aryl and biaryl compounds having MCH modulatory activity
摘要 Disclosed are compounds of the general structure shown in formula (I) Wherein: Ar1 is unsubstituted or substituted phenyl, wherein the substituents number from 0 to 5, may be the same or different and are independently selected from the group consisting of H, CN, F, CI, Br, I, and OH; M is H or R with R being a C1-C6 straight chain alkyl or branched alkyl or a C3-C7 cycloalkyl; Z is (Ar2-NH-C(=O)-) where Ar2 is an unsubstituted or substituted phenyl wherein the substituents number from 0 to 5, may be the same or different and are independently selected from the group consisting of F, CI, Br, I, R, and CF3; n = 0 to 6; p = 1; R1 may be the same or different and is independently selected from the group consisting of NH2; NHR; N(R)2; or the structures shown in formula (II); where n is defined above; and R2 is H or alkyl. Further disclosed is the use of compounds of formula (I) in the preparation of a pharmaceutical composition for use in the treatment of obesity.
申请公布号 NZ527680(A) 申请公布日期 2005.07.29
申请号 NZ20020527680 申请日期 2002.03.19
申请人 PHARMACOPEIA DRUG DISCOVERY, INC 发明人 HOBBS, DOUGLAS W;GUO, TAO;HUNTER, RACHAEL C;GU, HUIZHONG
分类号 C07D295/12;A61K31/12;A61K31/137;A61K31/166;A61K31/17;A61K31/18;A61K31/192;A61K31/341;A61K31/36;A61K31/381;A61K31/40;A61K31/4025;A61K31/4045;A61K31/417;A61K31/4409;A61K31/4468;A61K31/4535;A61K31/454;A61K31/4545;A61K31/495;A61K31/5375;A61K45/00;A61P3/04;A61P3/10;A61P25/18;A61P43/00;C07C233/78;C07C237/20;C07C255/58;C07C255/60;C07C271/52;C07C271/54;C07C275/28;C07C275/30;C07C275/32;C07C275/34;C07C311/06;C07C311/07;C07C311/08;C07C311/13;C07C311/18;C07C311/19;C07C317/32;C07D207/08;C07D207/09;C07D207/12;C07D207/14;C07D209/14;C07D209/16;C07D211/58;C07D213/38;C07D213/40;C07D213/63;C07D213/75;C07D213/89;C07D233/36;C07D233/61;C07D233/64;C07D261/18;C07D295/13;C07D295/155;C07D295/205;C07D307/14;C07D317/58;C07D333/20;C07D333/38;C07D409/12;C07D413/12;C07D471/04;(IPC1-7):C07C275/40;C07C15/12 主分类号 C07D295/12
代理机构 代理人
主权项
地址